Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.5185
-0.0014 (-0.27%)
At close: Jul 1, 2026, 4:00 PM EDT
0.5130
-0.0055 (-1.06%)
After-hours: Jul 1, 2026, 7:38 PM EDT
Valion Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
52
Market Cap
1.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
| Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
| Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 29.57M |
| VivoSim Labs | 142.00K |
| Biodexa Pharmaceuticals | 104.90K |
| Azitra | 7.50K |
| Virax Biolabs Group | 2.99K |
VBIO News
- 6 days ago - AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS - PRNewsWire
- 20 days ago - Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures - PRNewsWire
- 4 weeks ago - Valion Bio Transcript: AGM 2026 - Transcripts
- 6 weeks ago - VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME - PRNewsWire
- 6 weeks ago - Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform - TheFly
- 6 weeks ago - Valion Bio reports Q1 EPS ($2.23) vs. ($2.52) last year - TheFly
- 6 weeks ago - Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform - PRNewsWire
- 6 weeks ago - Valion Bio Earnings Call Transcript: Q1 2026 - Transcripts